On Jan. 4, 2017, Abbott announced it had completed the acquisition of St. Jude Medical for $25 billion. St. Jude Medical became a wholly-owned subsidiary of Abbott.

St. Jude’s portfolio in atrial fibrillation, heart failure, structural heart and chronic pain complemented Abbott’s coronary interventions and mitral valve disease business.